Panbela Provides Business Update and Reports Q4 and FY 2024

MINNEAPOLIS, March 26, 2024 -- Panbela Therapeutics, Inc. , a clinical stage company developing disruptive therapeutics for the treatment of patients with urgent unmet medical needs, today...

Related Keywords

Chile , Australia , Japan , United States , China , American , Tammy Groene , Jenniferk Simpson , Nasdaq , Nasdaq Stock Market , Johns Hopkins University School Of Medicine , Panbela Therapeutics Inc , Adoption Of Commission Implementing Decision , Pediatric Neuroblastoma Program , European Union , Research Agreement , American Association For Cancer Research , Globenewswire Inc , Sponsored Research Agreement , Cancer Center , Evaluate Polyamine Metabolic Inhibitor Therapy , Hopkins University School , Poster Presentation , Cancer Research , Clinical Data , New Approaches , Neuroblastoma Therapy , Typei Diabetes , Cancer Risk Reduction Trial , Commission Implementing Decision , Orphan Designation , Safety Analysis , Data Safety Monitoring Board , Diabetes Data , Polyamine Biosynthesis Preserves , Cell Function , Cell Rep , European Patent , Novel Process , New Patent , Access Code , Private Securities Litigation Reform Act , Annual Report , Quarterly Reports , Current Reports , Comprehensive Loss , Balance Sheets , Cash Flows , Markets ,